These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 612039)

  • 1. [e-Antigens in patients with chronic hemodialysis].
    Gmelin K; Thamer G; Tschöpe W; Kommerell B
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():581-2. PubMed ID: 612039
    [No Abstract]   [Full Text] [Related]  

  • 2. [B virus chronic hepatitis in the haemodialysed uraemic patient. Correlation between hepatic lesions and the presence of antigen e in 12 patients (author's transl)].
    Simon P; Menault M; Tanquerel T; Herry D
    Nouv Presse Med; 1978 Sep; 7(32):2837-40. PubMed ID: 714664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B markers among dialysis patients without hepatitis B surface antigen or antibody.
    Kelly TJ; Sanchez TV; Patterson MJ; Mayor GH
    Proc Clin Dial Transplant Forum; 1980; 10():165-8. PubMed ID: 7346842
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hepatitis in hemodialysis units].
    Kotzaurek R; Krassnitzky O; Pesendorfer F; Wewalka F
    Schweiz Med Wochenschr; 1971 Nov; 101(44):1581-5. PubMed ID: 5141579
    [No Abstract]   [Full Text] [Related]  

  • 5. Virus B hepatitis in hemodialysis centers.
    Soulier JP; Jungers P; Zingraff J
    Adv Nephrol Necker Hosp; 1976; 6():383-411. PubMed ID: 828452
    [No Abstract]   [Full Text] [Related]  

  • 6. [Serum hepatitis and hemodialysis. Australia antigen in patients and personnel of a dialysis center].
    Berthold H; Heinze V; Vonend E
    Anglo Ger Med Rev; 1972 Mar; 6(3):137-41. PubMed ID: 4655634
    [No Abstract]   [Full Text] [Related]  

  • 7. [Surface antigen (HBsAg) and core antibody (anti-HBc) in chronic uremia during periodic hemodialysis treatment of hepatitis B patients. Correlation with viral replication markers (HBeAg and DNA polymerase activity)].
    Buongiorno R; Dentico P; Santantonio T; Frappampina V; Spinelli A; Amato M; Pastore G
    Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2076-82. PubMed ID: 7459119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple hepatitis B virus markers in dialysis patients.
    Acchiardo S; Cockrell S
    Trans Am Soc Artif Intern Organs; 1982; 28():308-11. PubMed ID: 7164253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus infection in Thai hemodialysis patients.
    Phanichphant S; Mekswasdi P; Charuvichitratana J
    Southeast Asian J Trop Med Public Health; 1985 Jun; 16(2):280-4. PubMed ID: 4071201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-A, non-B hepatitis in patients with chronic hemodialysis].
    Bansky G; Grob PJ; Joller-Jemelka HI; Zaruba K; Iselin H; Gloor HJ
    Schweiz Med Wochenschr; 1984 Oct; 114(41):1423-7. PubMed ID: 6436969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of the behavior of HBsAg and anti-HBs in 4 dialysis centers].
    Wagner L; Kasprus J; Kösters W; Schwarzbeck A; Twittenhoff WD; Strauch M
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():409-11. PubMed ID: 1029225
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis B surface antigen is a better monitor of infectivity compared with antibody to hepatitis B core antigen in hemodialysis patients.
    Otani K; Kasuga Y; Kimura Y; Mukaide M; Yanai H; Koyama T; Fujise K
    Ther Apher Dial; 2010 Aug; 14(4):434-5. PubMed ID: 20649766
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis B infection in institutionalized Down's syndrome inmates: a longitudinal study with five hepatitis B virus markers.
    Hawkes RA; Boughton CR; Schroeter DR; Decker RH; Overby LR
    Clin Exp Immunol; 1980 Jun; 40(3):478-86. PubMed ID: 6448112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The significance of studying the HBe system in the prognosis of patients with acute and chronic viral hepatitis Be].
    Perisić-Savić M; Nastić-Mirić D
    Srp Arh Celok Lek; 1983; 111(9-10):1343-50. PubMed ID: 6681452
    [No Abstract]   [Full Text] [Related]  

  • 15. Serological markers of hepatitis in hemodialysis patients and staff.
    Kelly TJ; Hourani MR; Patterson MJ; Mayor GH
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():179-82. PubMed ID: 756042
    [No Abstract]   [Full Text] [Related]  

  • 16. Presence of HBeAg, DNA polymerase activity, Dane particle in different categories of HBsAg carriers and evidence of hepatitis type B infection in their family contacts.
    Zanetti AR; Ferroni P
    Boll Ist Sieroter Milan; 1977 Mar; 56(1):79-86. PubMed ID: 861076
    [No Abstract]   [Full Text] [Related]  

  • 17. HBeAg/anti-HBe system in the acute phase of HBsAg-positive hepatitis as a predictive test of developing chronic hepatitis.
    Caredda F; D'Arminio Monforte A; Rossi E; Cultraro D; Marescotti C; Moroni M
    Boll Ist Sieroter Milan; 1981; 60(6):468-79. PubMed ID: 7344717
    [No Abstract]   [Full Text] [Related]  

  • 18. [The behavior of the HBeAg-anti-HBe system in chronic hepatitis].
    Musca A; Cordova C; Barnaba V; Bonavita MS; Zaccari C; Levrero M
    Minerva Dietol Gastroenterol; 1983; 29(1):19-26. PubMed ID: 6843853
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatitis B in hemodialyzed patients].
    Nagy E; Kovács M; Albert K; Tolnai A
    Orv Hetil; 1985 Dec; 126(49):3021-2. PubMed ID: 4080366
    [No Abstract]   [Full Text] [Related]  

  • 20. [Australia-SH antigen in patients undergoing hemodialysis].
    Kommerell B; Sanwald R; Ritz E; Andrassy K; Rapp W
    Bibl Haematol; 1971; 37():243-4. PubMed ID: 5138910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.